Evan L. O’Keefe

1.4k total citations
43 papers, 865 citations indexed

About

Evan L. O’Keefe is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Evan L. O’Keefe has authored 43 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 13 papers in Physiology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Evan L. O’Keefe's work include Fatty Acid Research and Health (8 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiovascular and exercise physiology (6 papers). Evan L. O’Keefe is often cited by papers focused on Fatty Acid Research and Health (8 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiovascular and exercise physiology (6 papers). Evan L. O’Keefe collaborates with scholars based in United States, United Kingdom and Canada. Evan L. O’Keefe's co-authors include James H. O’Keefe, Carl J. Lavie, James J. DiNicolantonio, Andrew Elagizi, Richard V. Milani, Keri Marshall, Richard Isaacson, Gary W. Small, John H. Helzberg and Harshal Patil and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Evan L. O’Keefe

39 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan L. O’Keefe United States 17 223 199 172 123 121 43 865
Choy‐Lye Chei Japan 20 206 0.9× 158 0.8× 139 0.8× 239 1.9× 142 1.2× 38 948
Alireza Heidari‐Bakavoli Iran 17 211 0.9× 189 0.9× 214 1.2× 205 1.7× 182 1.5× 43 947
Fengyang Huang Mexico 16 126 0.6× 236 1.2× 119 0.7× 66 0.5× 144 1.2× 70 846
Wen-Shang Hou China 10 91 0.4× 239 1.2× 133 0.8× 230 1.9× 106 0.9× 12 1.0k
Márcia Kiyomi Koike Brazil 17 171 0.8× 136 0.7× 108 0.6× 37 0.3× 69 0.6× 76 838
Huaixing Li China 14 71 0.3× 169 0.8× 101 0.6× 156 1.3× 118 1.0× 15 838
Salman Bhatti United States 5 125 0.6× 79 0.4× 121 0.7× 145 1.2× 162 1.3× 13 731
Fabian Eichelmann Germany 18 139 0.6× 369 1.9× 192 1.1× 312 2.5× 129 1.1× 33 1.2k
Damian Skrypnik Poland 17 116 0.5× 211 1.1× 154 0.9× 113 0.9× 129 1.1× 60 736

Countries citing papers authored by Evan L. O’Keefe

Since Specialization
Citations

This map shows the geographic impact of Evan L. O’Keefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan L. O’Keefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan L. O’Keefe more than expected).

Fields of papers citing papers by Evan L. O’Keefe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan L. O’Keefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan L. O’Keefe. The network helps show where Evan L. O’Keefe may publish in the future.

Co-authorship network of co-authors of Evan L. O’Keefe

This figure shows the co-authorship network connecting the top 25 collaborators of Evan L. O’Keefe. A scholar is included among the top collaborators of Evan L. O’Keefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan L. O’Keefe. Evan L. O’Keefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Keefe, Evan L., et al.. (2025). Time to bystander CPR and survival for witnessed out-of-hospital cardiac arrest. Resuscitation. 209. 110566–110566.
2.
Tintle, Nathan, et al.. (2025). The association between plasma omega-3 fatty acids and suicidal ideation/self-harm in the United Kingdom Biobank. Lipids in Health and Disease. 24(1). 364–364.
3.
O’Keefe, Evan L., et al.. (2025). Associations Between Plasma Omega‐3 and Fish Oil Use With Risk of Atrial Fibrillation in the UK Biobank. Journal of the American Heart Association. 14(24). e043031–e043031.
4.
Verma, Subodh, Javed Butler, Barry A. Borlaug, et al.. (2024). Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 84(17). 1603–1614. 17 indexed citations
5.
O’Keefe, Evan L., James H. O’Keefe, Hussam Abuissa, et al.. (2024). Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword. Progress in Cardiovascular Diseases. 91. 3–9. 5 indexed citations
6.
O’Keefe, Evan L., et al.. (2024). Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality. Mayo Clinic Proceedings. 99(4). 534–541. 8 indexed citations
7.
O’Keefe, James H., et al.. (2024). Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy. Progress in Cardiovascular Diseases. 89. 102–112. 10 indexed citations
8.
O’Keefe, Evan L., et al.. (2024). Abstract Su1203: Temporal Trends in Post-Resuscitation Fever After In-Hospital Cardiac Arrest. Circulation. 150(Suppl_1). 1 indexed citations
9.
O’Keefe, Evan L., Philip Jones, William E. Boden, et al.. (2024). Abstract 4143127: Association of Serial Seattle Angina Questionnaire Assessments with Clinical Events in Chronic Coronary Disease: Insights from the ISCHEMIA Trial. Circulation. 150(Suppl_1). 1 indexed citations
10.
O’Keefe, James H., et al.. (2023). PCSK9 inhibitor, ezetimibe, and bempedoic acid: Evidence-based therapies for statin-intolerant patients. Progress in Cardiovascular Diseases. 79. 12–18. 24 indexed citations
11.
O’Keefe, James H., et al.. (2023). SGLT inhibitors for improving Healthspan and lifespan. Progress in Cardiovascular Diseases. 81. 2–9. 15 indexed citations
12.
O’Keefe, Evan L., et al.. (2022). Early-Onset Cardiovascular Disease From Cocaine, Amphetamines, Alcohol, and Marijuana. Canadian Journal of Cardiology. 38(9). 1342–1351. 13 indexed citations
13.
O’Keefe, Evan L., et al.. (2021). Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification. The American Journal of Cardiology. 160. 46–52. 36 indexed citations
14.
O’Keefe, James H., et al.. (2020). Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention. Journal of Alzheimer s Disease. 78(2). 619–626. 92 indexed citations
15.
O’Keefe, Evan L., James H. O’Keefe, & Carl J. Lavie. (2019). Exercise Counteracts the Cardiotoxicity of Psychosocial Stress. Mayo Clinic Proceedings. 94(9). 1852–1864. 33 indexed citations
16.
O’Keefe, Evan L., William S. Harris, James J. DiNicolantonio, et al.. (2019). Sea Change for Marine Omega-3s. Mayo Clinic Proceedings. 94(12). 2524–2533. 21 indexed citations
17.
O’Keefe, James H., Michael E. Nassif, Melissa Magwire, Evan L. O’Keefe, & Carl J. Lavie. (2019). The elephant in the room: Why cardiologists should stop ignoring type 2 diabetes. Progress in Cardiovascular Diseases. 62(4). 364–369. 19 indexed citations
18.
O’Keefe, James H., Evan L. O’Keefe, & Carl J. Lavie. (2018). Socially Interactive Exercise Improves Longevity: The Power of Playing with Friends. 1 indexed citations
19.
Patil, Harshal, Nirav Patil, Evan L. O’Keefe, et al.. (2014). Increased intrathoracic and hepatic visceral adipose tissue independently correlates with coronary artery calcification in asymptomatic patients. Journal of Nuclear Cardiology. 21(5). 880–889. 7 indexed citations
20.
Chhabra, Rajiv, James H. O’Keefe, Harshal Patil, et al.. (2013). Association of Coronary Artery Calcification With Hepatic Steatosis in Asymptomatic Individuals. Mayo Clinic Proceedings. 88(11). 1259–1265. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Choy‐Lye Chei Breakdown of academic impact, for papers by Alireza Heidari‐Bakavoli Breakdown of academic impact, for papers by Fengyang Huang Breakdown of academic impact, for papers by Wen-Shang Hou Breakdown of academic impact, for papers by Márcia Kiyomi Koike Breakdown of academic impact, for papers by Huaixing Li Breakdown of academic impact, for papers by Salman Bhatti Breakdown of academic impact, for papers by Fabian Eichelmann Breakdown of academic impact, for papers by Damian Skrypnik
Rankless by CCL
2026